Skip to main content

Table 1 National prevalence of S.aureus, MRSA and Pseudomonas aeruginosa in DFU across Africa

From: Update on prevalence and antimicrobial resistance of Staphylococcus aureus and Pseudomonas aeruginosa isolated from diabetic foot ulcers in Africa: a systematic review and meta-analysis

Country

Total bacterial isolates

Pooled prevalence (%) 95% CI

S. aureus

I2 (P-value)

MRSA

I2 (P-value)

P. aeruginosa

I2 (P-value)

Algeria

508

28.5 (24.65–32.69)

88.56 (82.26 92.62)

14.4 (11.44–17.73)

95.64 (82.26–92.62)

11.61 (8.96–14.73)

89.95 (84.67–93.41)

Burkina Faso

71

32.4 (21.76–44.55)

0.0 (0.00–5.06)

2.82 (0.34–9.81)

Cameroon

255

13.3 (9.41–18.13)

0.0 (0.00–1.44)

10.98 (7.42–15.48)

Egypt

566

12.2 (9.61–15.17)

2.5 (1.36–4.12)

16.61 (13.63–19.94)

Ethiopia

235

27.2 (21.65–33.40)

11.1 (7.36–15.79)

16.17 (11.70–21.51)

Ghana

96

19.8 (12.36–29.17)

6.3 (2.33–13.11)

19.79 (12.36–29.17)

Kenya

80

17.5 (9.91–27.62)

0.0 (0.00–4.51)

7.50 (2.80–15.61)

Morocco

307

13.7 (10.04–18.04)

0.7 (0.08–2.33)

3.90 (2.04–6.73)

Nigeria

991

21.1 (18.59–23.76)

0.0 (0.00–0.37)

18.37 (16.00–20.92)

Sudan

606

24.9 (21.52–28.56)

4.6 (3.09–6.62)

19.31 (16.24–22.68)

Tanzania

146

8.2 (4.32–13.92)

0.0 (0.00–2.50)

4.80 (1.94–9.63)

Tunisia

141

26.2 (19.20–34.31)

4.3 (1.58–9.03)

5.67 (2.48–10.87)

Uganda

122

18.9 (12.34–26.93)

4.9 (1.83–10.40)

18.85 (12.34–26.93)